Related Experiment Video
Updated: May 21, 2025
Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea
Published on: December 6, 2016
Impact of Upper Airway Comorbidities and Tonsil/Adenoid Synergistic Effects on Pediatric OSA Severity
Yiwei Feng1, Weisong Cai1, Qiang Xie1,2
1Department of Otorhinolaryngology, Head and Neck Surgery, Zhongnan Hospital of Wuhan University, Wuhan, People's Republic of China.
Insights
Pediatric obstructive sleep apnea (OSA) severity is worsened by comorbidities like chronic rhinosinusitis, nasal deviation, and malocclusion. These conditions synergistically reduce surgical effectiveness, highlighting the need for comprehensive treatment strategies.
Area of Science:
- Pediatric Otolaryngology
- Sleep Medicine
- Respiratory Physiology
Background:
- Obstructive sleep apnea (OSA) is a common condition in children.
- Tonsillar and adenoid hypertrophy are primary causes of pediatric OSA.
- The impact of upper airway comorbidities on OSA severity and treatment efficacy requires further investigation.
Purpose of the Study:
- To identify factors influencing pediatric OSA severity.
- To assess the synergistic effects of upper airway comorbidities with tonsillar/adenoid hypertrophy on ventilation.
- To evaluate the impact of these factors on surgical outcomes.
Main Methods:
- Retrospective cohort study of 404 pediatric OSA patients (6-10 years).
- Logistic regression analysis to identify risk factors.
- Cone-beam computed tomography (CBCT) for 3D airway modeling.
- Computational fluid dynamics (CFD) for simulating airway resistance and surgical outcomes.
Main Results:
- Tonsillar/adenoid hypertrophy (Grade 3), comorbidities, and obesity are independent risk factors for OSA severity.
- A dose-response relationship exists between comorbidity number and OSA severity (OR=9.392 for triple comorbidities).
- Tonsillectomy and adenoidectomy (T&A) improve ventilation, but comorbidities significantly reduce surgical efficacy.
Conclusions:
- T&A is valuable for pediatric OSA, but comorbidities substantially mitigate its effectiveness.
- Synergistic effects of comorbidities negatively impact ventilation and postoperative outcomes.
- Comprehensive management addressing both hypertrophy and comorbidities is crucial for pediatric OSA treatment.
Purpose:
To investigate the factors influencing the severity of obstructive sleep apnea (OSA) in children and to elucidate the synergistic effects of upper airway comorbidities (chronic rhinosinusitis, nasal septum deviation and malocclusion) with tonsillar and adenoid hypertrophy on ventilation efficiency.
Patients And Methods:
A total of 404 pediatric patients with OSA aged 6-10 years diagnosed between January 2022 and January 2025 were included in this retrospective cohort study and underwent logistic regression analysis to identify the risk factors for pediatric OSA. Three-dimensional upper airway models under various comorbidity states were constructed via cone‒beam computed tomography (CBCT), and postoperative airway resistance changes were calculated via computational fluid dynamics (CFD) simulation and simulated surgery.
Results:
Grade 3 tonsillar or adenoid hypertrophy, the presence of comorbidities, and overweight/obesity were identified as independent risk factors for increased OSA severity. A dose‒response relationship was observed between the number of comorbidities and OSA severity, with the highest odds ratio (OR=9.392, 95% CI=2.459-35.875) for triple-positive comorbidities. CFD simulations demonstrated that tonsillectomy and adenoidectomy (T&A) significantly improved ventilation function across different OSA severities. Comorbidities influence airway resistance, with postoperative resistance in children with triple-positive comorbidities approaching preoperative levels in those without comorbidities.
Conclusion:
T&As hold therapeutic value for pediatric OSA patients, but comorbidities significantly mitigate surgical efficacy through synergistic effects.
More Related Videos
Related Concept Videos
01:30Tonsillitis I: Introduction
Etiology
Three primary contributing factors have been identified.
01:21Sleep Apnea
The condition is more prevalent among...
01:17Other Pulmonary Disorders
01:23Chronic Pharyngitis
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
01:19Factors Affecting Pulmonary Ventilation
Alveolar Surface Tension
The alveolar fluid lines the luminal surface of the alveoli and exerts a force called surface tension. This force is caused by the polar water molecules in the liquid being more strongly attracted to each...
01:23Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...